Systemic administration of CpG oligodeoxynucleotide and levamisole as adjuvants for gene-gun-delivered antitumor DNA vaccines

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Šmahel, Michal ^a   Poláková, Ingrid ^a   Sobotková, Eva ^a   Vajdová, Eva ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; LEVAMISOLE; ONCOPROTEIN; PLASMID DNA; CANCER VACCINE; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN E7;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GENE GUN; GENE GUN IMMUNIZATION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; BIOLISTIC TRANSFORMATION; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLISTICS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNITY; LEVAMISOLE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; OLIGODEOXYRIBONUCLEOTIDES; PAPILLOMAVIRUS E7 PROTEINS; VACCINES, DNA;

EID: 84855183224     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/176759     Document Type: Article

References (33)

1. Wolff J. A., Malone R. W., Williams P., Wang Chong, Acsadi G., Jani A., Felgner P. L., Direct gene transfer into mouse muscle in vivo Science 1990 247 4949 1465 1468
2. Tang D., DeVit M., Johnston S. A., Genetic immunization is a simple method for eliciting an immune response Nature 1992 356 6365 152 154
3. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A., Hawe L. A., Leander K. R., Martinez D., Perry H. C., Shiver J. W., Montgomery D. L., Liu M. A., Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259 5102 1745 1749 (Pubitemid 23114660)
4. Rice J., Ottensmeier C. H., Stevenson F. K., DNA vaccines: precision tools for activating effective immunity against cancer Nature Reviews Cancer 2008 8 2 108 120 (Pubitemid 351161331)
5. Sasaki S., Takeshita F., Xin K. Q., Ishii N., Okuda K., Adjuvant formulations and delivery systems for DNA vaccines Methods 2003 31 3 243 254 (Pubitemid 37162797)
6. Thomsen L. L., Topley P., Daly M. G., Brett S. J., Tite J. P., Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery Vaccine 2004 22 13-14 1799 1809 (Pubitemid 38447228)
7. Zuber A. K., Brve A., Engstrm G., Zuber B., Ljungberg K., Fredriksson M., Benthin R., Isaguliants M. G., Sandstrm E., Hinkula J., Wahren B., Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA Vaccine 2004 22 13-14 1791 1798 (Pubitemid 38447227)
8. Jin H., Li Y., Ma Z., Zhang F., Xie Q., Gu D., Wang B., Effect of chemical adjuvants on DNA vaccination Vaccine 2004 22 21-22 2925 2935 (Pubitemid 38900672)
9. Huijun L., Xiaowei H., Ying Z., Min Z., Mingxiao M., Hongyong Z., Minglan J., Guoshun S., Leili J., Yue J., Xu L., Kuoshi J., Ningyi J., Enhancing effects of the chemical adjuvant levamisole on the DNA vaccine pVIR-P12A-IL18-3C Microbiology and Immunology 2008 52 9 440 446
10. Wang X., Jin H., Du X., Cai C., Yu Y., Zhao G., Su B., Huang S., Hu Y., Luo D., She R., Luo X., Zeng X., Yi X., Wang B., The protective efficacy aganist Schistosoma japonicum infection by immunization with DNA vaccine and levamisole as adjuvant in mice Vaccine 2008 26 15 1832 1845
11. Janssen P. A. J., Levamisole as an adjuvant in cancer treatment Journal of Clinical Pharmacology 1991 31 5 396 400
12. Lombardi L., Morelli F., Cinieri S., Santini D., Silvestris N., Fazio N., Orlando L., Tonini G., Colucci G., Maiello E., Adjuvant colon cancer chemotherapy: where we are and where we'll go Cancer Treatment Reviews 2010 36 3 S34 S41
13. Manoj S., Babiuk L. A., Van Drunen Littel-van Den Hurk S., Approaches to enhance the efficacy of DNA vaccines Critical Reviews in Clinical Laboratory Sciences 2004 41 1 1 39 (Pubitemid 38299788)
14. Vollmer J., Krieg A. M., Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists Advanced Drug Delivery Reviews 2009 61 3 195 204
15. Bode C., Zhao G., Steinhagen F., Kinjo T., Klinman D. M., CpG DNA as a vaccine adjuvant Expert Review of Vaccines 2011 10 4 499 511
16. Mellor A. L., Baban B., Chandler P. R., Manlapat A., Kahler D. J., Munn D. H., Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling Journal of Immunology 2005 175 9 5601 5605 (Pubitemid 41508038)
17. Wingender G., Garbi N., Schumak B., Jngerkes F., Endl E., von Bubnoff D., Steitz J., Striegler J., Moldenhauer G., Tting T., Heit A., Huster K. M., Takikawa O., Akira S., Busch D. H., Wagner H., Hmmerling G. J., Knolle P. A., Limmer A., Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO European Journal of Immunology 2006 36 1 12 20 (Pubitemid 43116387)
18. Wilson N. S., Behrens G. M. N., Lundie R. J., Smith C. M., Waithman J., Young L., Forehan S. P., Mount A., Steptoe R. J., Shortman K. D., de Koning-Ward T. F., Belz G. T., Carbone F. R., Crabb B. S., Heath W. R., Villadangos J. A., Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity Nature Immunology 2006 7 2 165 172 (Pubitemid 43135882)
19. Seif A. E., Barrett D. M., Milone M., Brown V. I., Grupp S. A., Reid G. S. D., Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses Blood 2009 114 12 2459 2466
20. mahel M., ma P., Ludvkov V., Vonka V., Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells Virology 2001 281 2 231 238 (Pubitemid 32881139)
21. Ludvkov V., Hamskov E., Sobotkov E., Lucansky V., Smahel M., Vonka V., Use of polyclonal rabbit antibodies for detection of the bcr-abl fusion zone in cells transfected with experimental bcr-abl DNA vaccines International Journal of Oncology 2005 27 1 265 274
22. mahel M., Pokorn D., Mackov J., Vlask J., Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli -glucuronidase Journal of Gene Medicine 2004 6 10 1092 1101
23. mahel M., ma P., Ludvkov V., Marinov I., Pokorn D., Vonka V., Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules Vaccine 2003 21 11-12 1125 1136 (Pubitemid 36142051)
24. Lin K. Y., Guarnieri F. G., Staveley-O'Carroll K. F., Levitsky H. I., August J. T., Pardoll D. M., Wu T. C., Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Research 1996 56 1 21 26 (Pubitemid 26010379)
25. McLaughlin J., Chianese E., Witte O. N., In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome Proceedings of the National Academy of Sciences of the United States of America 1987 84 18 6558 6562
26. Nmekov A. A., Strnsk R., ubrtov J., Kutinov L., Othal P., Hainz P., Mareov L., roller V., Hamkov E., Vonka V., Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface Cancer Immunology, Immunotherapy 2002 51 2 111 119 (Pubitemid 34230726)
27. Lucansky V., Sobotkova E., Tachezy R., Duskova M., Vonka V., DNA vaccination against bcr-abl-positive cells in mice International Journal of Oncology 2009 35 4 941 951
28. Stevenson F. K., Ottensmeier C. H., Rice J., DNA vaccines against cancer come of age Current Opinion in Immunology 2010 22 2 264 270
29. Krieg A. M., Development of TLR9 agonists for cancer therapy Journal of Clinical Investigation 2007 117 5 1184 1194 (Pubitemid 46718403)
30. Chen L. Y., Lin Y. L., Chiang B. L., Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells Clinical and Experimental Immunology 2008 151 1 174 181
31. Iwasaki A., Medzhitov R., Toll-like receptor control of the adaptive immune responses Nature Immunology 2004 5 10 987 995 (Pubitemid 41057715)
32. Krieg A. M., Efler S. M., Wittpoth M., Al Adhami M. J., Davis H. L., Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist Journal of Immunotherapy 2004 27 6 460 471 (Pubitemid 39447354)
33. Kim H. A., Ko H. M., Ju H. W., Kim K. J., Roh S. G., Lee H. K., Im S. Y., CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells Cancer Letters 2009 274 1 160 164